A placebo-controlled trial of recombinant human ciliary neurotrophic (rhCNTF) factor in amyotrophic lateral sclerosis

Annals of Neurology

Volumn 39, Issue 2, 1996, Pages 256-260

  Miller, Robert G ^a   Petajan, Jack H ^a   Bryan, Wilson W ^a   Armon, Carmel ^a   Barohn, Richard J ^a   Goodpasture, Jessie C ^a   Hoagland, Rebecca J ^a   Parry, Gareth J ^a   Ross, Mark A ^a   Stromatt, Scott C ^a  

^a CALIFORNIA PACIFIC MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CILIARY NEUROTROPHIC FACTOR;

ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; ASTHENIA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COUGHING; DIGESTIVE SYSTEM FUNCTION DISORDER; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; HUMAN; LUNG FUNCTION; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; MUSCLE ISOMETRIC CONTRACTION; MUSCLE STRENGTH; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SALIVATION; SURVIVAL; WEIGHT REDUCTION;

ADULT; AGED; AGED, 80 AND OVER; AMYOTROPHIC LATERAL SCLEROSIS; CILIARY NEUROTROPHIC FACTOR; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; HUMANS; MIDDLE AGED; NERVE GROWTH FACTORS; NERVE TISSUE PROTEINS; PROSPECTIVE STUDIES; RECOMBINANT PROTEINS; SURVIVAL ANALYSIS;

EID: 9044219848     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.410390215     Document Type: Article

References (15)

1. Rowland LP. Amyotrophic lateral sclerosis. Curr Opin Neurol 1994;7:310-315
2. Manthrope M. Ciliary neurotrophic factors. In: Rush RA, ed. Nerve growth factors. New York: John Wiley, 1989:31-53
3. Houenou LJ, Oppenheim RW. Motor neuron death during development, following injury and in neurological disease. Semin Neurosci 1994;6:283-289
4. Houenou LJ, Li L, Lo AC, et al. Naturally occurring and axotomy-induced motor neuron death and its prevention by neurotrophic agents: a comparison between chick and mouse. Prog Brain Res 1994;102:209-218
5. Miller RG, Bryan WW, Munsat TL, et al. Safety, tolerability and pharmacokinetics of recombinant human ciliary neurotrophic factor (rhCNTF) in patients with amyotrophic lateral sclerosis (ALS). Ann Neurol 1993;34:241 (Abstract)
6. Brooks BR, Sanjak M, Mitsumoto H, et al. Recombinant human ciliary neurotrophic factor (rhCNTF) in amyotrophic lateral sclerosis (ALS) patients: Phase I-II safety, tolerability and pharmacokinetic studies. Neurology 1993;43:A416 (Abstract)
7. El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. Subcommittee on Motor Neuron Diseases/Amyotrophic Lateral Sclerosis of the World Federation of Neurology Research Group on Neuromuscular Diseases and the El Escorial Clinical limits of amyotrophic lateral sclerosis workshop contributors. J Neurol Sci 1994;124(suppl):96-107
8. Ross MA, Parry GJ, Miller RG, et al. Evaluation of amyotrophic lateral sclerosis diagnostic criteria (ALSDC) for a controlled trial of recombinant human ciliary neurotrophic factor (rhCNT). Neurology 1995;45(suppl 4):A280 (Abstract)
9. Andres PL, Finison LJ, Conlon T, et al. Use of composite scores (Megascores) to measure deficit in ALS. Neurology 1988;38:405-408
10. Ringel SP, Murphy JR, Alderson MK, et al. The natural history of amyotrophic lateral sclerosis. Neurology 1993;43: 1316-1322
11. Cohen J. Statistical power analysis for the behavioral sciences. Hillsdale, NJ: Lawrence Erlbaum Associates, 1987
12. McGuire D, Garrison L, Armon C, et al. Relationship of the Tufts Quantitative Neuromuscular Exam (TQNE) and the Sickness Impact Profile (SIP) in Measuring Progression of ALS. Neurology 1995 (in press)
13. Dittrich F, Thoenen H, Sendtner M. Ciliary neurotrophic factor: pharmacokinetics and acute phase response in rat. Ann Neurol 1994;35:151-163
14. Curtis R, Adryan KM, Zhu Y, et al. Retrograde axonal transport of ciliary neurotrophic factor is increased by peripheral nerve injury. Nature 1993;365:253-255
15. Bryan WW, Barohn RJ, Murphy JR, et al. Placebo versus natural history in an ALS clinical Trial. Neurology 1995;45(supp 4):A280-A281 (Abstract)